MedPath

Detecting Hypotension By Continuous Non-invasive Arterial Pressure Monitoring

Not Applicable
Conditions
Hypotension
Interventions
Registration Number
NCT02532270
Lead Sponsor
Fudan University
Brief Summary

The purpose of this study is to determine whether continuous non-invasive arterial pressure (CNAP) monitoring is beneficial to maintain maternal hemodynamic stability and improve the outcomes of maternal and fetal comparing with intermittent oscillometric non-invasive arterial pressure (NIAP)measurement during spinal anaesthesia for cesarean section .

Detailed Description

Peri-operative hypotension and fluctuation of arterial blood pressure (BP) during spinal anaesthesia are common. Hypotension causes maternal side-effects such as unconsciousness, dizziness, nausea, and vomiting. The potential fetal side-effects are caused by a reduction in the uterine blood flow with consequent reduced oxygen supply and acidosis reflected by impaired blood gas analyses and impaired Apgar scores. Because of the potential harm to the fetus and the dependency of fetal oxygenation on maternal arterial pressure (AP), it has been strongly recommended to closely monitor mother's arterial pressure and to treat hypotension immediately. Non-invasive arterial pressure (NIAP) measurement is a common method for monitoring in clinical. These hypotension episodes probably would be detected with delay by NIAP measurement on account of its discontinuous. A monitor for continuous non-invasive arterial pressure monitoring (CNAPTM Monitor 500, CNSystems Medizintechnik AG,Graz, Austria) using the volume-clamped method. It can monitor timely and provide beat-to-beat value of arterial pressure.

The purpose of this study is to determine whether continuous non-invasive arterial pressure (CNAP) monitoring is beneficial to maintain maternal hemodynamic stability and improve the outcomes of maternal and fetal.

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
100
Inclusion Criteria
  • scheduled for elective caesarean section with spinal anaesthesia
  • pregnancy week above 36
Exclusion Criteria
  • age<18 yr
  • cardiac arrhythmia
  • vascular pathologies of the upper limbs (recent vascular surgery, Raynaud's disease, vascular stenosis)
  • contraindication for spinal anaesthesia
  • emergency case

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Group CphenylephrineArterial pressure of the patients in Group C is measured by continuous non-invasive arterial pressure (CNAP).When systolic blood pressure decreased by over 20% of the basic value or systolic blood pressure lower than 100mmHg after spinal anaesthesia,phenylephrine was administered 50ug .If systolic blood pressure did not improve after 1 minute,phenylephrine was administered repeatedly until systolic blood pressure return to normal.
Group NphenylephrineArterial pressure of the patients in Group N is measured by intermittent oscillometric non-invasive arterial pressure (NIAP).When systolic blood pressure decreased by over 20% of the basic value or systolic blood pressure lower than 100mmHg after spinal anaesthesia,phenylephrine was administered 50ug .If systolic blood pressure did not improve after 1 minute,phenylephrine was administered repeatedly until systolic blood pressure return to normal.
Primary Outcome Measures
NameTimeMethod
the maximum change of systolic blood pressure(SBP),assessed using continuous non-invasive arterial pressure device or intermittent oscillometric arterial pressure measurementbetween the spinal anesthetic injection and the delivery of the fetus and placenta,assessed up to 30 mins

(baseline SBP-minimum SBP)/baseline SBP

Secondary Outcome Measures
NameTimeMethod
the incidence of nausea and vomiting on account of hypotensionbetween the spinal anesthetic injection and the delivery of the fetus and placenta,assessed up to 30 mins

The presence of nausea and vomiting was measured on a 3-point scale of 1,2, and 3 indicating no nausea and no vomiting, nausea only, and both nausea and vomiting, respectively. Assessments were done at 1-minute intervals after the spinal injection until 25 min.

Detecting the occurrence of hypotensionbetween the spinal anesthetic injection and the delivery of the fetus and placenta,assessed up to 30 mins

systolic blood pressure decreased by over 20% of the baseline or systolic blood pressure lower than 100mmHg

the incidence of dizziness on account of hypotensionbetween the spinal anesthetic injection and the delivery of the fetus and placenta,assessed up to 30 mins

assessment:yes=patient had dizziness,no=patient had no dizziness

Neonatal outcome was assessed with Apgar scoresbetween the spinal anesthetic injection and the delivery of the fetus and placenta,assessed up to 30 mins
umbilical cord blood gases analysis at birthbetween the spinal anesthetic injection and the delivery of the fetus and placenta,assessed up to 30 mins
the incidence of dyspnea on account of hypotensionbetween the spinal anesthetic injection and the delivery of the fetus and placenta,assessed up to 30 mins

assessment:yes=patient had dyspnea,no=patient had no dyspnea

Trial Locations

Locations (1)

Department of Anesthesiology, Department of Obstetrics and Gynecology Hospital, Fudan University

🇨🇳

Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath